SCHEMBL5547108

SCHEMBL5547108

Cc1c(C(C)C(=O)O)c2c(F)c(O)ccc2n1C(=O)c1cccc(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
PIK3CD O00329 1/20 0.36
PLA2G7 Q13093 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.36
NOTUM Q6P988 1/20 0.36
PTGS2 P35354 3/20 0.35
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5557670 1.00 AKR1C3 (0.40) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2
SCHEMBL5554693 1.00 AKR1C3 (0.40) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2
SCHEMBL5553766 0.91 PIK3CD (0.38) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2
SCHEMBL5553770 0.91 PIK3CD (0.38) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2
SCHEMBL5550614 0.90 PTGS2 (0.41) AKR1C3AKR1C2KMT2AMEN1NOTUM
SCHEMBL6422844 0.90 AKR1C3 (0.39) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2
SCHEMBL5553556 0.90 PTGS2 (0.41) AKR1C3AKR1C2KMT2AMEN1NOTUM
SCHEMBL5554699 0.90 PTGS2 (0.41) AKR1C3AKR1C2KMT2AMEN1NOTUM
SCHEMBL5559481 0.89 SMN1; SMN2 (0.36) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2
SCHEMBL5559486 0.89 SMN1; SMN2 (0.36) AKR1C3AKR1C2PIK3CDPLA2G7SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293542-A1 Selective Cox-2 Inhibitors IRONWOOD PHARMACEUTICALS, INC. 2007-12-20 US disclosed
US-20070293542-A1 Selective Cox-2 Inhibitors IRONWOOD PHARMACEUTICALS, INC. 2007-12-20 US disclosed
US-20070293542-A1 Selective Cox-2 Inhibitors IRONWOOD PHARMACEUTICALS, INC. 2007-12-20 US disclosed
EP-1643961-A4 COX-2 AND FAAH INHIBITORS MICROBIA INC (US) 2007-09-12 EP disclosed
WO-2006050120-A2 SYNTHESIS OF COX-2 AND FAAH INHIBITORS MICROBIA, INC. (US) 2006-05-11 WO disclosed
EP-1643961-A2 COX-2 AND FAAH INHIBITORS Microbia, Inc. (US) 2006-04-12 EP disclosed
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed
WO-2005037227-A2 SELECTIVE COX-2 INHIBITORS MICROBIA, INC. (US) 2005-04-28 WO disclosed
WO-2005002525-A2 COX-2 AND FAAH INHIBITORS MICROBIA, INC. (US) 2005-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293542-A1 Selective Cox-2 Inhibitors PTGS2, FAAH2, PTGES2 AKR1C3 1000/4885AKR1C2 862/4885PIK3CD 2633/4885
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 AKR1C3 577/4885AKR1C2 563/4885PIK3CD 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.